Sedana Medical appoints Johannes Doll as new CEO
Sedana Medical’s (publ) (SEDANA: FN Stockholm) Board of Directors has appointed Johannes Doll as the company’s new CEO. Johannes Doll will take office no later than November 1, 2021, succeeding Christer Ahlberg, who, as announced previously, will leave his position. The Board of Directors has appointed Sedana Medical's Commercial Director Jens Lindberg as Acting CEO from June 1.Johannes Doll is currently Chief Commercial Officer (EVP and Chief Commercial Officer) at Orexo, where he worked for almost eight years. Doll has about 16 years of experience from the life science industry, including